Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 392

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

New sources of pancreatic β-cells

Bonner-Weir, Susan, Weir, Gordon C·2005·Nature Biotechnology
DOI 10.1038/nbt1115
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nbt1115

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 73

  1. Writing team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290, 2159–2167 (2003). · DOI · Paper page
  2. Shapiro, A.M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230–238 (2000). · DOI · Paper page
  3. Robertson, R.P. Islet transplantation as a treatment for diabetes—a work in progress. N. Engl. J. Med. 350, 694–705 (2004). · DOI · Paper page
  4. Trucco, M. Regeneration of the pancreatic beta cell. J. Clin. Invest. 115, 5–12 (2005). · doi:10.1172/jci200523935
  5. Bonner-Weir, S. Perspective: postnatal pancreatic beta cell growth. Endocrinology 141, 1926–1929 (2000). · DOI · Paper page
  6. Tyrberg, B., et al. Stimulated endocrine cell proliferation and differentiation in transplanted human pancreatic islets: effects of the ob gene and compensatory growth of the implantation organ. Diabetes 50, 301–307 (2001). · DOI
  7. Zulewski, H. et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50, 521–533 (2001). · DOI · Paper page
  8. Linning, K.D. et al. Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential. Pancreas 29, e64–e76 (2004). · DOI
  9. Gershengorn, M.C. et al. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 306, 2261–2264 (2004). · DOI · Paper page
  10. Lechner, A., Nolan, A.L., Blacken, R.A. & Habener, J.F. Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem. Biophys. Res. Commun. 327, 581–588 (2005). · DOI
  11. Grunert, S., et al. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4, 657–665 (2003). · DOI · Paper page
  12. Ling, Z. & Pipeleers, D.G. Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J. Clin. Invest. 98, 2805–2812 (1996). · DOI · Paper page
  13. Hardikar, A.A., et al. Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates. Proc. Natl. Acad. Sci. USA 100, 7117–7122 (2003). · DOI · Paper page
  14. Soria, B. et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in strepotozotocin-induced diabetic mice. Diabetes 49, 157–162 (2000). · DOI · Paper page
  15. Assady, S. et al. Insulin production by human embryonic stem cells. Diabetes 50, 1691–1697 (2001). · DOI · Paper page
  16. Leon-Quinto, T., et al. In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 47, 1442–1451 (2004). · DOI · Paper page
  17. Lumelsky, N. et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389–1393 (2001). · DOI · Paper page
  18. Hori, Y. et al. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc. Natl. Acad. Sci. USA 99, 16105–16110 (2002). · DOI · Paper page
  19. Kahan, B.W. et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes 52, 2016–2024 (2003). · DOI
  20. Blyszczuk, P. et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc. Natl. Acad. Sci. USA 100, 998–1003 (2003). · DOI · Paper page
  21. Miyazaki, S., Yamato, E. & Miyazaki, J. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 53, 1030–1037 (2004). · DOI · Paper page
  22. Segev, H., et al. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 22, 265–274 (2004). · DOI · Paper page
  23. Rajagopal, J., Anderson, W.J., Kume, S., Martinez, O.I. & Melton, D.A. Insulin staining of ES cell progeny from insulin uptake. Science 299, 363 (2003). · DOI · Paper page
  24. Hansson, M. et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 53, 2603–2609 (2004). · DOI · Paper page
  25. Sipione, S., et al. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 47, 499–508 (2004). · DOI · Paper page
  26. Kania, G., et al. The generation of insulin-producing cells from embryonic stem cells–a discussion of controversial findings. Int. J. Dev. Biol. 48, 1061–1064 (2004). · DOI
  27. Hori, Y., Gu, X., Xie, X. & Kim, S.K. Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med. 2, e103 (2005). · DOI
  28. Schuit, F., et al. Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells. Diabetes (suppl. 3) 51, S326–S332 (2002). · DOI
  29. Halban, P. A., et al. Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 50, 2181–2191 (2001). · DOI
  30. Weir, G.C. Can we make surrogate beta-cells better than the original? Semin. Cell Dev. Biol. 15, 347–357 (2004). · DOI
  31. Hanahan, D. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr. Opin. Immunol. 10, 656–662 (1998). · DOI · Paper page
  32. Devaskar, S.U. et al. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J. Biol. Chem. 269, 8445–8454 (1994). · DOI · Paper page
  33. Alarcon, C., et al. Synthesis and differentially regulated processing of proinsulin in developing chick pancreas, liver and neuroretina. FEBS Lett. 436, 361–366 (1998). · doi:10.1016/s0014-5793(98)01168-5
  34. Asahina, K. et al. Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells. Genes Cells 9, 1297–1308 (2004). · DOI
  35. Kubo, A. et al. Development of definitive endoderm from embryonic stem cells in culture. Development 131, 1651–1662 (2004). · DOI · Paper page
  36. Ku, H.T. et al. Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells 22, 1205–1217 (2004). · DOI
  37. Suzuki, A., Nakauchi, H. & Taniguchi, H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 53, 2143–2152 (2004). · DOI · Paper page
  38. Seaberg, R.M. et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22, 1115–1124 (2004). · DOI · Paper page
  39. Weir, G.C. & Bonner-Weir, S. Beta-cell precursors–a work in progress. Nat. Biotechnol. 22, 1095–1096 (2004). · DOI
  40. Bonner-Weir, S. et al. The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr. Diabetes 5, 16–22 (2004). · DOI · Paper page
  41. Lardon, J., Huyens, N., Rooman, I. & Bouwens, L. Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas. Virchows Arch. 444, 61–65 (2004). · DOI
  42. Baeyens, L. et al. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 48, 49–57 (2005). · DOI · Paper page
  43. Rooman, I., et al. Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas. Gastroenterology 121, 940–949 (2001). · DOI
  44. Rooman, I. & Bouwens, L. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan. Diabetologia 47, 259–265 (2004). · DOI
  45. Jensen, J.N. et al. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 128, 728–741 (2005). · DOI · Paper page
  46. Bonner-Weir, S. et al. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 97, 7999–8004 (2000). · DOI · Paper page
  47. Gao, R. et al. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 52, 2007–2015 (2003). · DOI · Paper page
  48. Suarez-Pinzon, W.L., et al. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet β-cells from pancreatic duct cells and an increase in functional β-cell mass. J. Clin. Endocrinol. Metab. 90, 3401–3409 (2005). · DOI · Paper page
  49. Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41–49 (2002). · DOI · Paper page
  50. Ianus, A., Holz, G.G., Theise, N.D. & Hussain, M.A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 111, 843–850 (2003). · DOI
  51. Hess, D. et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21, 763–770 (2003). · DOI · Paper page
  52. Mathews, V. et al. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 53, 91–98 (2004). · DOI · Paper page
  53. Tang, D.Q. et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53, 1721–1732 (2004). · DOI · Paper page
  54. Zorina, T.D. et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 21, 377–388 (2003). · DOI
  55. Kodama, S., et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302, 1223–1227 (2003). · DOI · Paper page
  56. Ogawa, N., et al. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 53, 1700–1705 (2004). · DOI
  57. Chatenoud, L., Primo, J. & Bach, J.F. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158, 2947–2954 (1997). · DOI · Paper page
  58. Fujita, Y., Cheung, A.T. & Kieffer, T.J. Harnessing the gut to treat diabetes. Pediatr. Diabetes (suppl. 2) 5, 57–69 (2004). · DOI
  59. Ferber, S. et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. 6, 568–572 (2000). · DOI · Paper page
  60. Ber, I. et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J. Biol. Chem. 278, 31950–31957 (2003). · DOI · Paper page
  61. Kaneto, H. et al. A crucial role of mafA as a novel therapeutic target for diabetes. J. Biol. Chem. 280, 15047–15052 (2005). · DOI
  62. Kojima, H. et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med. 9, 596–603 (2003). · DOI · Paper page
  63. Zalzman, M. et al. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc. Natl. Acad. Sci. USA 100, 7253–7258 (2003). · DOI · Paper page
  64. Kaneto, H. et al. PDX-1/VP16 fusion protein, together with neuroD or ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes 54, 1009–1022 (2005). · DOI · Paper page
  65. Yang, L. et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. USA 99, 8078–8083 (2002). · DOI · Paper page
  66. Cao, L.Z., Tang, D.Q., Horb, M.E., Li, S.W. & Yang, L.J. High glucose is necessary for complete maturation of Pdx1–VP16-expressing hepatic cells into functional insulin-producing cells. Diabetes 53, 3168–3178 (2004). · DOI
  67. Bruning, J.C. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561–572 (1997). · DOI · Paper page
  68. Butler, A.E. et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102–110 (2003). · DOI · Paper page
  69. Rosenberg, L. et al. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann. Surg. 240, 875–884 (2004). · DOI
  70. Li, L., et al. Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 53, 608–615 (2004). · DOI
  71. Brubaker, P.L. & Drucker, D.J. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145, 2653–2659 (2004). · DOI · Paper page
  72. Ratner, R.E., Feeley, D., Buse, J.B. & Schwartz, S.L. Double-blind, placebo-controlled trial of islet neogenesis gene associated protein (INGAP) in type 1 diabetes. Diabetes (suppl. 1) 54, 11-LB (late breaking abstract) (2005).
  73. Ratner, R.E., Feeley, D., Buse, J.B. & Fischer, J.S. Double-blind, placebo-controlled trial of islet neogenesis gene associated protein (INGAP) in type 2 diabetes. Diabetes (suppl. 1) 54, 12-LB (late breaking abstract) (2005).

Cited by

See all 392

Metadata

Authors
Bonner-Weir, S., & Weir, G. C.
Venue
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
Published
2005-07
Volume
23
Issue
7
Pages
857-861
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
DOI
10.1038/nbt1115
OpenAlex
W1540138335
Cited by
392
References
4
FWCI
38.83
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New sources of pancreatic β-cells. https://app.cochat.ai/papers/10.1038/nbt1115
The paper
Bonner-Weir, S., & Weir, G. C. (2005). New sources of pancreatic β-cells. Nature Biotechnology. https://doi.org/10.1038/nbt1115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.